| scholarly article | Q13442814 |
| P2093 | author name string | R K Menon | |
| C R Williams | |||
| S J Karpen | |||
| L A Denson | |||
| A Shaufl | |||
| H S Bajwa | |||
| P2860 | cites work | A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse) | Q24654776 |
| Mouse BTEB3, a new member of the basic transcription element binding protein (BTEB) family, activates expression from GC-rich minimal promoter regions | Q28594128 | ||
| Real time quantitative PCR | Q29616373 | ||
| Growth hormone insensitivity: physiologic and genetic basis, phenotype, and treatment | Q33732033 | ||
| The Sp-family of transcription factors | Q33778355 | ||
| In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects | Q35830756 | ||
| Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors | Q37381843 | ||
| Transcriptional regulation of fatty acid synthase gene and ATP citrate-lyase gene by Sp1 and Sp3 in rat hepatocytes(1). | Q38316908 | ||
| Role of the Sp family of transcription factors in the ontogeny of growth hormone receptor gene expression | Q38318287 | ||
| Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease | Q38341520 | ||
| G10BP, an E1A-inducible negative regulator of Sp1, represses transcription of the rat fibronectin gene | Q40017282 | ||
| A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages | Q40902387 | ||
| A retinoblastoma susceptibility gene product, RB, targeting protease is regulated through the cell cycle | Q41065598 | ||
| Structure and expression of the mouse growth hormone receptor/growth hormone binding protein gene | Q41682314 | ||
| Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture | Q42435114 | ||
| Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid | Q42485695 | ||
| Growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids with alternative 5'-untranslated regions are differentially expressed in mouse liver and placenta | Q42686565 | ||
| A novel method for real time quantitative RT-PCR. | Q46544663 | ||
| Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. | Q52553797 | ||
| Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. | Q54110118 | ||
| Kinetics of endotoxin-induced acute-phase protein gene expression and its modulation by TNF-alpha monoclonal antibody | Q58463630 | ||
| Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements | Q62819809 | ||
| The role of cis-acting promoter elements in tissue-specific albumin gene expression | Q69593323 | ||
| Nucleotide sequence of the 5'-terminal region of rat 18S ribosomal DNA | Q70918368 | ||
| Establishment of the role of IL-6 and TNF receptor 1 using gene knockout mice | Q72814494 | ||
| Growth failure in children with inflammatory bowel disease: a prospective study | Q72898882 | ||
| A novel phenotype for Lardon dwarfism in miniature Bos indicus cattle suggests that the expression of growth hormone receptor 1A in liver is required for normal growth | Q73339862 | ||
| Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation | Q73561156 | ||
| GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors | Q74590896 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | TNF | Q18032037 |
| P304 | page(s) | 1451-8 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding | |
| P478 | volume | 107 |
| Q53876696 | Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis. |
| Q45872470 | Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis |
| Q34368943 | Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance |
| Q28572668 | Decreased expression levels of rat liver glutathione S-transferase A2 and albumin during the acute phase response are mediated by HNF1 (hepatic nuclear factor 1) and IL6DEX-NP |
| Q33913108 | Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1β |
| Q28271735 | Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity |
| Q28567884 | Expression of genes controlling transport and catabolism of prostaglandin E2 in lipopolysaccharide fever |
| Q28066795 | Gene environment interaction in periphery and brain converge to modulate behavioral outcomes: Insights from the SP1 transient early in life interference rat model |
| Q46984099 | Glutamine and interleukin-1beta interact at the level of Sp1 and nuclear factor-kappaB to regulate argininosuccinate synthetase gene expression |
| Q59335779 | Growth Hormone Receptor Gene Expression Increase Reflects Nutritional Status Improvement in Patients Affected by Crohn's Disease |
| Q33755171 | Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease. |
| Q35997118 | Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I. |
| Q35569439 | Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia |
| Q34426164 | Growth problems in children with IBD. |
| Q83567214 | Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women |
| Q51550379 | Human growth hormone receptor (GHR) expression in obesity: II. Regulation of the human GHR gene by obesity-related factors. |
| Q52112602 | IL-6-overexpression brings about growth impairment potentially through a GH receptor defect. |
| Q37046776 | Immunogenomics reveal molecular circuits of diclofenac induced liver injury in mice |
| Q50062805 | Increases in IGF-1 after Anti-TNF-α Therapy are Associated with Bone and Muscle Accrual in Pediatric Crohn's Disease |
| Q34673479 | Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis |
| Q45925195 | Insulin-like growth factor-I levels predict weight, height and protein catabolism in children and adolescents with cystic fibrosis. |
| Q40152013 | Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes |
| Q36013461 | Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways |
| Q38290424 | Mechanism of negative regulation of rat glutathione S-transferase A2 by the cytokine interleukin 6 |
| Q37588490 | Mechanisms of growth impairment in pediatric Crohn's disease |
| Q30252705 | Mice with infectious colitis exhibit linear growth failure and subsequent catch-up growth related to systemic inflammation and IGF-1. |
| Q36891517 | Nuclear factor-kappaB is a critical mediator of Ste20-like proline-/alanine-rich kinase regulation in intestinal inflammation |
| Q33859400 | Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis |
| Q34478319 | Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha. |
| Q44107660 | Role of Redox Imbalance in the Molecular Mechanisms Responsible for Immunosenescence |
| Q36028202 | Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass |
| Q35106293 | Sex differences in statural growth impairment in Crohn's disease: role of IGF-1. |
| Q89820471 | Signal Transduction for TNFα-Induced Type II SOCS Expression and Its Functional Implication in Growth Hormone Resistance in Carp Hepatocytes |
| Q35569874 | Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis |
| Q38359975 | Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney |
| Q36766514 | TNF-α-induced NF-κB activation upregulates microRNA-150-3p and inhibits osteogenesis of mesenchymal stem cells by targeting β-catenin |
| Q36617109 | The inhibitory effects of interleukin-1 on growth hormone action during catabolic illness |
| Q33369658 | The interferon-gamma-mediated inhibition of lipoprotein lipase gene transcription in macrophages involves casein kinase 2- and phosphoinositide-3-kinase-mediated regulation of transcription factors Sp1 and Sp3. |
| Q36308581 | The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity |
| Q33848783 | Transcriptional regulation of bone morphogenetic protein 4 by tumor necrosis factor and its relationship with age-related macular degeneration |
| Q40711804 | Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis |
| Q90604267 | Tumor necrosis factor-α regulates skeletal myogenesis by inhibiting SP1 interaction with cis-acting regulatory elements within the Fbxl2 gene promoter |
| Q35761249 | Tumour necrosis factor alpha blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis. |
Search more.